File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Zotarolimus-eluting stent utilization in small-vessel coronary artery disease (ZEUS)

TitleZotarolimus-eluting stent utilization in small-vessel coronary artery disease (ZEUS)
Authors
KeywordsAged
Cardiovascular Agents/*administration & dosage
Coronary Angiography
Coronary Restenosis/etiology
Coronary Stenosis/radiography/*therapy
*Drug-Eluting Stents
Female
Humans
Male
Middle Aged
Myocardial Infarction/etiology
Percutaneous Coronary Intervention/adverse effects/*instrumentation
Prosthesis Design
Retrospective Studies
Sirolimus/administration & dosage/*analogs & derivatives
Time Factors
Treatment Outcome
Issue Date2014
Citation
Heart and Vessels, 2014, v. 29 n. 1, p. 29-34 How to Cite?
AbstractThe role of the second-generation zotarolimus-eluting stent RESOLUTE in small-vessel coronary artery disease is unclear. The aim of this study was examine the angiographic results of RESOLUTE in de novo coronary lesions of >/=50 % diameter stenosis in target vessels
Persistent Identifierhttp://hdl.handle.net/10722/207701
ISSN
2015 Impact Factor: 2.293
2015 SCImago Journal Rankings: 0.709

 

DC FieldValueLanguage
dc.contributor.authorJim, MHen_US
dc.contributor.authorYiu, KHen_US
dc.contributor.authorFung, RCen_US
dc.contributor.authorHo, HHen_US
dc.contributor.authorNg, AKen_US
dc.contributor.authorSiu, DCWen_US
dc.contributor.authorChow, WHen_US
dc.date.accessioned2015-01-19T04:20:40Z-
dc.date.available2015-01-19T04:20:40Z-
dc.date.issued2014en_US
dc.identifier.citationHeart and Vessels, 2014, v. 29 n. 1, p. 29-34en_US
dc.identifier.issn0910-8327en_US
dc.identifier.urihttp://hdl.handle.net/10722/207701-
dc.description.abstractThe role of the second-generation zotarolimus-eluting stent RESOLUTE in small-vessel coronary artery disease is unclear. The aim of this study was examine the angiographic results of RESOLUTE in de novo coronary lesions of >/=50 % diameter stenosis in target vessels </=2.5 mm. From August 2008 to April 2010, 142 symptomatic patients with 159 lesions who fitted the inclusion criteria were treated with RESOLUTE. The mean age of patients was 66 +/- 10 years, with male predominance (66 %). Diabetes mellitus was found in 62 (43.7 %) patients, whereas multivessel disease was observed in 105 (73.9 %). The mean stent size and length used were 2.33 +/- 0.13 and 22 +/- 8 mm, respectively. Follow-up angiography was performed on 143 (89.9 %) lesions in 127 (89.4 %) patients at a mean of 10.3 +/- 3.6 months. Angiographic restenosis was found in 9 (6.3 %) lesions; the late loss was 0.26 +/- 0.34 mm. At 1-year follow-up there were four cardiovascular deaths, two nonfatal myocardial infarctions, and six repeated revascularizations. The resultant major adverse cardiac event rate was 8.5 %. The use of RESOLUTE to treat small-vessel disease is associated with good clinical and angiographic outcomes at 1 year.en_US
dc.languageengen_US
dc.relation.ispartofHeart and Vesselsen_US
dc.subjectAgeden_US
dc.subjectCardiovascular Agents/*administration & dosageen_US
dc.subjectCoronary Angiographyen_US
dc.subjectCoronary Restenosis/etiologyen_US
dc.subjectCoronary Stenosis/radiography/*therapyen_US
dc.subject*Drug-Eluting Stentsen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectMyocardial Infarction/etiologyen_US
dc.subjectPercutaneous Coronary Intervention/adverse effects/*instrumentationen_US
dc.subjectProsthesis Designen_US
dc.subjectRetrospective Studiesen_US
dc.subjectSirolimus/administration & dosage/*analogs & derivativesen_US
dc.subjectTime Factorsen_US
dc.subjectTreatment Outcomeen_US
dc.titleZotarolimus-eluting stent utilization in small-vessel coronary artery disease (ZEUS)en_US
dc.typeArticleen_US
dc.identifier.emailYiu, KH: khkyiu@hku.hken_US
dc.identifier.authorityYiu, KH=rp01490en_US
dc.identifier.doi10.1007/s00380-013-0327-0en_US
dc.identifier.hkuros254855-
dc.identifier.volume29en_US
dc.identifier.issue1en_US
dc.identifier.spage29en_US
dc.identifier.epage34en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats